Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Mehl

Orthopaedic Surgery Olympia Fields, IL Medical Doctor

NPI 1588632913 CMS profile 26701

20201 Crawford Ave, Suite 1400, Olympia Fields, IL 60461

Open in the dashboard

General payments

$2,831

106 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Mehl of Olympia Fields, IL is reported in the CMS Open Payments database as having received $2,831 across 106 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 45th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $393 18
2024 General $246 8
2023 General $313 11
2022 General $488 11
2021 General $467 15
2020 General $474 19
2019 General $450 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Mehl
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to David Mehl were reported at $393. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year David Mehl Orthopaedic Surgery median Middle half National median
2019 $450 $644 $140–$2,844 $163
2020 $474 $312 $75–$1,860 $114
2021 $467 $520 $117–$2,495 $132
2022 $488 $598 $128–$2,731 $149
2023 $313 $461 $128–$2,264 $160
2024 $246 $497 $134–$2,475 $164
2025 $393 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Sales Inc. $1,062 18 payments
  2. Ferring Pharmaceuticals Inc. $551 27 payments
  3. Flexion Therapeutics, Inc. $345 23 payments
  4. Vertex Pharmaceuticals Incorporated $158 9 payments
  5. Stryker Corporation $97 2 payments
  6. ERMI Inc. $68 3 payments
  7. Sanofi-Aventis U.S. LLC $66 4 payments
  8. Catalyst OrthoScience $65 2 payments
  9. Pacira Pharmaceuticals Incorporated $56 2 payments
  10. Zimmer Biomet Holdings, Inc. $54 1 payment
  11. Other $309 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,831 106 payments
Products named General payments · program years 2019–2025
  1. EUFLEXXA $551 27 payments
  2. Zilretta $345 23 payments
  3. DYNACORD $285 6 payments
  4. JOURNAVX $158 9 payments
  5. CORAIL $146 1 payment
  6. MONOVISC $143 2 payments
  7. NA $109 2 payments
  8. IM NAILS $105 1 payment
  9. SIGMA $96 1 payment
  10. ATTUNE $96 2 payments
  11. Other $1,040 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

1,846

Median for Orthopedic Surgery: 203

Drug cost

$36,669

Median for Orthopedic Surgery: $1,433

Branded share of claims

64%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 1,145 $31,747
Ibuprofen Generic 76 $937
Acetaminophen-Codeine Acetaminophen With Codeine Brand 37 $581
Naproxen Generic 64 $533
Meloxicam Generic 153 $532
Tramadol Hcl Generic 82 $472
Celecoxib Generic 12 $416
Diclofenac Sodium Generic 47 $368
Cyclobenzaprine Hcl Generic 34 $342
Amoxicillin Generic 123 $266

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$167,687

Medicare's payments for the services billed

Medicare patients

524

Average age 75

Services billed

1,687

344 women, 180 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 40%
Ischemic heart disease 33%
Chronic kidney disease 28%
Heart failure 24%
Depression 24%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

106 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record